Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-08-043467
Filing Date
2008-02-29
Accepted
2008-02-29 14:50:06
Documents
13
Period of Report
2007-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 854736
2 AMENDED AND RESTATED 1994 EQUITY COMPENSATION PLAN dex101.htm EX-10.1 70675
3 ADOLOR CORP. AMENDED AND RESTATED 2003 STOCK-BASED INCENTIVE COMPENSATION PLAN dex102.htm EX-10.2 63323
4 LICENSE AND COLLABORATION AGREEMENT BETWEEN THE COMPANY AND PFIZER INC. dex1014.htm EX-10.14 573015
5 AMENDMENT LETTER AGREEMENT BETWEEN THE COMPANY AND MICHAEL R. DOUGHERTY dex1020.htm EX-10.20 4013
6 PERFORMANCE STOCK OPTION AWARD BETWEEN THE COMPANY AND MICHAEL R. DOUGHERTY dex1022.htm EX-10.22 11619
7 FORM OF PERFORMANCE DEFERRED STOCK AWARD dex1029.htm EX-10.29 13273
8 CONSENT OF KPMG LLP dex231.htm EX-23.1 2422
9 SECTION 302 CEO CERTIFICATION dex311.htm EX-31.1 9029
10 SECTION 302 CFO CERTIFICATION dex312.htm EX-31.2 9017
11 SECTION 906 CEO CERTIFICATION dex321.htm EX-32.1 2753
12 SECTION 906 CFO CERTIFICATION dex322.htm EX-32.2 2746
13 GRAPHIC g88917g13i03.jpg GRAPHIC 78521
  Complete submission text file 0001193125-08-043467.txt   1726263
Mailing Address 700 PENNSYLVANIA DRIVE EXTON PA 19341
Business Address 700 PENNSYLVANIA DRIVE EXTON PA 19341
ADOLOR CORP (Filer) CIK: 0001076167 (see all company filings)

EIN.: 311429198 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-30039 | Film No.: 08654847
SIC: 2834 Pharmaceutical Preparations